Hennie G. Raterman

The interferon type I signature towards prediction of non-response to rituximab in rheumatoid arthritis patients

Hennie G. Raterman, Saskia Vosslamber, Sander de Ridder et al. · Arthritis Research & Therapy · 2012 · 184 citations · Full text

Low dose, add-on prednisolone in patients with rheumatoid arthritis aged 65+: the pragmatic randomised, double-blind placebo-controlled GLORIA trial

Maarten Boers, Linda Hartman, Daniela Opriș-Belinski et al. · Annals of the Rheumatic Diseases · 2022 · 149 citations · Full text

A non-inferiority trial of an attenuated combination strategy (‘COBRA-light‘) compared to the original COBRA strategy: clinical results after 26 weeks

Debby den Uyl, Marieke M. ter Wee, Maarten Boers et al. · Annals of the Rheumatic Diseases · 2013 · 100 citations · Full text

Rheumatoid arthritis is associated with a high prevalence of hypothyroidism that amplifies its cardiovascular risk

Hennie G. Raterman, Vokko P. van Halm, Alexandre E. Voskuyl et al. · Annals of the Rheumatic Diseases · 2007 · 82 citations

HDL protein composition alters from proatherogenic into less atherogenic and proinflammatory in rheumatoid arthritis patients responding to rituximab

Hennie G. Raterman, Han Levels, Alexandre E. Voskuyl et al. · Annals of the Rheumatic Diseases · 2012 · 77 citations